D

Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450

Watchlist Manager
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Watchlist
Price: 17 460 KRW -0.57% Market Closed
Market Cap: 767.6B KRW
Have any thoughts about
Dongkook Pharmaceutical Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Dongkook Pharmaceutical Co Ltd stock under the Base Case scenario is 19 115.36 KRW. Compared to the current market price of 17 460 KRW, Dongkook Pharmaceutical Co Ltd is Undervalued by 9%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
19 115.36 KRW
Undervaluation 9%
Intrinsic Value
Price
D
Worst Case
Base Case
Best Case

Valuation Backtest
Dongkook Pharmaceutical Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Dongkook Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Dongkook Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Dongkook Pharmaceutical Co Ltd

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Dongkook Pharmaceutical Co Ltd

Provide an overview of the primary business activities
of Dongkook Pharmaceutical Co Ltd.

What unique competitive advantages
does Dongkook Pharmaceutical Co Ltd hold over its rivals?

What risks and challenges
does Dongkook Pharmaceutical Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Dongkook Pharmaceutical Co Ltd.

Provide P/S
for Dongkook Pharmaceutical Co Ltd.

Provide P/E
for Dongkook Pharmaceutical Co Ltd.

Provide P/OCF
for Dongkook Pharmaceutical Co Ltd.

Provide P/FCFE
for Dongkook Pharmaceutical Co Ltd.

Provide P/B
for Dongkook Pharmaceutical Co Ltd.

Provide EV/S
for Dongkook Pharmaceutical Co Ltd.

Provide EV/GP
for Dongkook Pharmaceutical Co Ltd.

Provide EV/EBITDA
for Dongkook Pharmaceutical Co Ltd.

Provide EV/EBIT
for Dongkook Pharmaceutical Co Ltd.

Provide EV/OCF
for Dongkook Pharmaceutical Co Ltd.

Provide EV/FCFF
for Dongkook Pharmaceutical Co Ltd.

Provide EV/IC
for Dongkook Pharmaceutical Co Ltd.

Show me price targets
for Dongkook Pharmaceutical Co Ltd made by professional analysts.

What are the Revenue projections
for Dongkook Pharmaceutical Co Ltd?

How accurate were the past Revenue estimates
for Dongkook Pharmaceutical Co Ltd?

What are the Net Income projections
for Dongkook Pharmaceutical Co Ltd?

How accurate were the past Net Income estimates
for Dongkook Pharmaceutical Co Ltd?

What are the EPS projections
for Dongkook Pharmaceutical Co Ltd?

How accurate were the past EPS estimates
for Dongkook Pharmaceutical Co Ltd?

What are the EBIT projections
for Dongkook Pharmaceutical Co Ltd?

How accurate were the past EBIT estimates
for Dongkook Pharmaceutical Co Ltd?

Compare the revenue forecasts
for Dongkook Pharmaceutical Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Dongkook Pharmaceutical Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Dongkook Pharmaceutical Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Dongkook Pharmaceutical Co Ltd compared to its peers.

Compare the P/E ratios
of Dongkook Pharmaceutical Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Dongkook Pharmaceutical Co Ltd with its peers.

Analyze the financial leverage
of Dongkook Pharmaceutical Co Ltd compared to its main competitors.

Show all profitability ratios
for Dongkook Pharmaceutical Co Ltd.

Provide ROE
for Dongkook Pharmaceutical Co Ltd.

Provide ROA
for Dongkook Pharmaceutical Co Ltd.

Provide ROIC
for Dongkook Pharmaceutical Co Ltd.

Provide ROCE
for Dongkook Pharmaceutical Co Ltd.

Provide Gross Margin
for Dongkook Pharmaceutical Co Ltd.

Provide Operating Margin
for Dongkook Pharmaceutical Co Ltd.

Provide Net Margin
for Dongkook Pharmaceutical Co Ltd.

Provide FCF Margin
for Dongkook Pharmaceutical Co Ltd.

Show all solvency ratios
for Dongkook Pharmaceutical Co Ltd.

Provide D/E Ratio
for Dongkook Pharmaceutical Co Ltd.

Provide D/A Ratio
for Dongkook Pharmaceutical Co Ltd.

Provide Interest Coverage Ratio
for Dongkook Pharmaceutical Co Ltd.

Provide Altman Z-Score Ratio
for Dongkook Pharmaceutical Co Ltd.

Provide Quick Ratio
for Dongkook Pharmaceutical Co Ltd.

Provide Current Ratio
for Dongkook Pharmaceutical Co Ltd.

Provide Cash Ratio
for Dongkook Pharmaceutical Co Ltd.

What is the historical Revenue growth
over the last 5 years for Dongkook Pharmaceutical Co Ltd?

What is the historical Net Income growth
over the last 5 years for Dongkook Pharmaceutical Co Ltd?

What is the current Free Cash Flow
of Dongkook Pharmaceutical Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Dongkook Pharmaceutical Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Dongkook Pharmaceutical Co Ltd

Current Assets 460.8B
Cash & Short-Term Investments 85.4B
Receivables 207.4B
Other Current Assets 168.1B
Non-Current Assets 440.6B
Long-Term Investments 130B
PP&E 281.3B
Intangibles 18.2B
Other Non-Current Assets 11.1B
Current Liabilities 230.5B
Accounts Payable 93.4B
Accrued Liabilities 7.9B
Short-Term Debt 41.7B
Other Current Liabilities 87.5B
Non-Current Liabilities 112.3B
Long-Term Debt 22.1B
Other Non-Current Liabilities 90.2B
Efficiency

Earnings Waterfall
Dongkook Pharmaceutical Co Ltd

Revenue
764.7B KRW
Cost of Revenue
-337B KRW
Gross Profit
427.6B KRW
Operating Expenses
-352.8B KRW
Operating Income
74.9B KRW
Other Expenses
-20.4B KRW
Net Income
54.5B KRW

Free Cash Flow Analysis
Dongkook Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Dongkook Pharmaceutical Co Ltd's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
Positive 1-Year Revenue Growth
54/100
Profitability
Score

Dongkook Pharmaceutical Co Ltd's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Dongkook Pharmaceutical Co Ltd's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Low D/E
High Altman Z-Score
Long-Term Solvency
80/100
Solvency
Score

Dongkook Pharmaceutical Co Ltd's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Dongkook Pharmaceutical Co Ltd

Wall Street analysts forecast Dongkook Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Dongkook Pharmaceutical Co Ltd is 26 010 KRW with a low forecast of 23 230 KRW and a high forecast of 29 400 KRW.

Lowest
Price Target
23 230 KRW
33% Upside
Average
Price Target
26 010 KRW
49% Upside
Highest
Price Target
29 400 KRW
68% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Dongkook Pharmaceutical Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Dongkook Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Dongkook Pharmaceutical Co Ltd

Country

Korea

Industry

Pharmaceuticals

Market Cap

767.7B KRW

Dividend Yield

1.03%

Description

DongKook Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceuticals. The company is headquartered in Seoul, Seoul. The company went IPO on 2007-05-29. The firm develops and provides remedies for oral troubles, skin troubles and gynecology diseases, contrast mediums, anesthetics, anticancer medicines and circulatory system agents. The company also provides other pharmaceuticals, such as remedies for arthritis and pancreatitis, antiphlogistic, anodynes, antibiotics and vitamins, as well as raw materials for pharmaceuticals. In addition, it is engaged in the rental business. The firm distributes its products within domestic market and to overseas markets, such as Japan, Germany, India, Brazil and Mexico, among others.

Contact

SEOUL
Seoul
Dongkook Bldg., 7, Teheran-ro 108-gil, Gangnam-gu
+82221919800
www.dkpharm.co.kr

IPO

2007-05-29

Employees

-

Officers

CEO, VP & Director
Mr. Heung-Ju Oh
CEO, Pres & Director
Mr. Young-Wook Lee
Director of Fin.
Mr. Hong-Ki Kim
Managing Director of Factory Management
Mr. Gyu-Jin Lee
Sr. Managing Director of Strategic Planning
Mr. Joon-Ho Song
Sr. Managing Director of PR
Mr. Soon-Kang Hong
Show More
Sr. Managing Director of Marketing
Mr. Hee-Soon Park
Sr. Managing Director of Sales
Mr. Je-Won Park
Show Less

See Also

Discover More
What is the Intrinsic Value of one Dongkook Pharmaceutical Co Ltd stock?

The intrinsic value of one Dongkook Pharmaceutical Co Ltd stock under the Base Case scenario is 19 115.36 KRW.

Is Dongkook Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 17 460 KRW, Dongkook Pharmaceutical Co Ltd is Undervalued by 9%.

Back to Top